Meme Koruyucu Cerrahi

De la Cruz Ku, G., Karamchandani, M., Chambergo-Michilot, D., Narvaez-Rojas, A. R., Jonczyk, M., Príncipe-Meneses, F. S., Posawatz, D., Nardello, S., & Chatterjee, A. (2022). Does Breast-Conserving Surgery with Radiotherapy have a Better Survival than Mastectomy? A Meta-Analysis of More than 1,500,000 Patients. Annals of Surgical Oncology, 29(10), 6163–6188.

Bland, K. I., Copeland, E. M., & Klimberg, V. S. (Eds.). The Breast: Comprehensive Management of Benign and Malignant Diseases. Elsevier.

Chatterjee A, Gass J, Patel K, Holmes D, Kopkash K, Peiris L, Peled A, Ryan J, El-Tamer M, Reiland J. A Consensus Definition and Classification System of Oncoplastic Surgery Developed by the American Society of Breast Surgeons. Ann Surg Oncol. 2019 Oct;26(11):3436-3444.

Czajka, M. L., & Pfeifer, C. (2023). Breast Cancer Surgery. StatPearls [Internet].

Barrio AV, Morrow M. Appropriate margin for lumpectomy excision of invasive breast cancer. Chin Clin Oncol. 2016 Jun;5(3):35.

American College of Radiology (ACR). (2013). ACR BI-RADS® Atlas, Breast Imaging Reporting and Data System. Reston, VA.

Gradishar, W. J., et al. (2024). NCCN Guidelines® Insights: Breast Cancer, Version 1.2024. Journal of the National Comprehensive Cancer Network.

Amin, M. B., et al. (Eds.). (2017). AJCC Cancer Staging Manual (8th ed.). Springer.

Cardoso, F., et al. (2019). 5th ESO-ESMO international consensus guidelines for advanced breast cancer.

Galimberti, V., et al. (2018). Nipple-sparing mastectomy: Who, when and how. The Breast, 38, 164-167.

Freeman MD, Gopman JM, Salzberg CA. The evolution of mastectomy surgical technique: from mutilation to medicine. Gland Surg. 2018 Jun;7(3):308-315.

Scheufler O, Fritschen Uv. Prophylactic mastectomy in women at high risk for breast cancer: indications and options. Handchir Mikrochir Plast Chir. 2008 Aug;40(4):239-47.

Black DM, Mittendorf EA. Landmark trials affecting the surgical management of invasive breast cancer. Surg Clin North Am. 2013 Apr;93(2):501-18.

Veronesi U, et al. Twenty-year follow-up of a randomized study comparing breast-conserving surgery with radical mastectomy for early breast cancer. N Engl J Med. 2002 Oct 17;347(16):1227-32.

Litière S, et al. Breast conserving therapy versus mastectomy for stage I-II breast cancer: 20 year follow-up of the EORTC 10801 phase 3 randomised trial. Lancet Oncol. 2012 Apr;13(4):412-9.

Christian MC, et al. The National Cancer Institute audit of the National Surgical Adjuvant Breast and Bowel Project Protocol B-06. N Engl J Med. 1995 Nov 30;333(22):1469-74.

Fisher B, Anderson S, Bryant J, et al. Twenty-year follow-up of a randomized trial comparing total mastectomy, lumpectomy, and lumpectomy plus irradiation for the treatment of invasive breast cancer. N Engl J Med2002;347:1233-41.

Anderson SJ, Wapnir I, Dignam JJ, et al. Prognosis after ipsilateral breast tumor recurrence and locoregional recurrences in patients treated by breast-conserving therapy in five National Surgical Adjuvant Breast and Bowel Project protocols of node-negative breast cancer. J Clin Oncol 2009;27:2466-73.

Wapnir IL, Anderson SJ, Mamounas EP, et al. Prognosis after ipsilateral breast tumor recurrence and locoregional recurrences in five National Surgical Adjuvant Breast and Bowel Project node-positive adjuvant breast cancer trials. J Clin Oncol 2006;24:2028-37.

Morrow, M., et al. (2014). Society of Surgical Oncology–American Society for Radiation Oncology consensus guideline on margins for breast-conserving surgery with whole-breast irradiation in stages I and II invasive breast cancer. Annals of Surgical Oncology, 21(3), 704-716.

Moran, M. S., et al. (2014). Society of Surgical Oncology-American Society for Radiation Oncology consensus guideline on margins for breast-conserving surgery with whole-breast irradiation in stages I and II invasive breast cancer. International Journal of Radiation Oncology, Biology, Physics, 88(3), 553-564.

Rahman, G. A. (2011). Breast Conserving Therapy: A surgical Technique where Little can Mean More. J Surg Tech Case Rep, 3(1), 1-4.

Niloff, P. H. (2012). Breast lumpectomy margins. Can J Surg, 55(5), E8.

Punglia, R. S., Morrow, M., Winer, E. P., et al. (2007). Local therapy and survival in breast cancer. N Engl J Med, 356, 2399–405.

McCahill, L. E., et al. (2012). Variability in reexcision following breast conservation surgery. JAMA, 307, 467–75.

Silverstein, M. J., et al. (2001). Ductal carcinoma in situ of the breast. J Am Coll Surg, 192, 196–214.

Di, G. H., et al. (2007). Surgical management of early breast cancer. Zhonghua Zhong Liu Za Zhi, 29(1), 62-5.

Kuerer, H. M. (2010). Kuerer's Breast Surgical Oncology. McGraw Hill Professional.

Kapoor MM, Patel MM, Scoggins ME. The Wire and Beyond: Recent Advances in Breast Imaging Preoperative Needle Localization. Radiographics. 2019 Nov-Dec;39(7):1886-1906.

Davey, M. G., et al. (2022). Radioactive seed localization versus wire-guided localization for non-palpable breast cancer: A systematic review and meta-analysis. Ann Surg Oncol.

Aydogan T, et al. Comparison of Radio-guided Occult Lesion Localization (ROLL) and Magnetic Occult Lesion Localization (MOLL) for Non-palpable Lesions: A Phantom Model Study. Clin Breast Cancer. 2020 Feb;20(1):e9-e13.

Krag DN, Anderson SJ, Julian TB, Brown AM, Harlow SP, Costantino JP, Ashikaga T, Weaver DL, Mamounas EP, Jalovec LM, Frazier TG, Noyes RD, Robidoux A, Scarth HM, Wolmark N. Sentinel-lymph-node resection compared with conventional axillary-lymph-node dissection in clinically node-negative patients with breast cancer: overall survival findings from the NSABP B-32 randomised phase 3 trial. Lancet Oncol. 2010 Oct;11(10):927-33.

Donker M, van Tienhoven G, Straver ME, et al. Radiotherapy or surgery of the axilla after a positive sentinel node in breast cancer (AMAROS): a randomised, multicentre, open-label, phase 3 non-inferiority trial. Lancet Oncol. 2014 Nov;15(12):1303-10.

Galimberti V, Cole BF, Viale G, et al. Effect of axillary dissection vs no axillary dissection on 10-year overall survival among women with breast cancer and sentinel node micrometastases: the IBCSG 23-01 randomized clinical trial. JAMA Oncol. 2018 Dec 1;4(12):1731-1733.

Costaz H, Rouffiac M, Boulle D, et al. Strategies in case of metastatic sentinel lymph node in breast cancer. Bull Cancer. 2020 Jun;107(6):672-685.

McLaughlin S, Cornell L, Mussallem D. Sexual function and breast-specific sensuality remain important after breast cancer surgery. Ann Surg Oncol. 2017;24(12):3475–6.

De La Cruz L, Blankenship S, Chatterjee A, Geha R, Nocera N, Czerniecki B, et al. Outcomes after oncoplastic breast-conserving surgery in breast cancer patients: a systematic literature review. Ann Surg Oncol. 2016;23(10):3247–58.

Cohen WA, Mundy LR, Ballard TN, Klassen A, Cano SJ, Browne J, et al. The BREAST-Q in surgical research: a review of the literature 2009–2015. J Plast Reconstr Aesthet Surg. 2016;69(2):149–62.

Losken A, Hart AM, Broecker JS, et al. Oncoplastic Breast Reduction Technique and Outcomes: An Evolution over 20 Years. Plast Reconstr Surg 2017;139:824e-33e.

Silverstein M, Savalia N, Khan S, Ryan J. Extreme oncoplasty: breast conservation for patients who need mastectomy. Breast J. 2015;21(1):52–9.

Mericli AF, Szpalski C, Schaverien MV, et al. The Latissimus Dorsi Myocutaneous Flap Is a Safe and Effective Method of Partial Breast Reconstruction in the Setting of Breast-Conserving Therapy. Plast Reconstr Surg2019;143:927e-35e.